PETER S. KIM - 02 Jun 2022 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
02 Jun 2022
Net transactions value
$0
Form type
4
Filing time
06 Jun 2022, 16:02:21 UTC
Previous filing
01 Nov 2021
Next filing
12 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Award $0 +11,918 $0.000000 11,918 02 Jun 2022 Common Stock 11,918 $6.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 2, 2022 (the "Vesting Start Date") or (ii) the Issuer's next annual meeting of stockholders.